Please assess the completion status of the following clinical trial:

Trial Title: Nicotine Vaccination and Nicotinic Receptor Occupancy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Current smoker who smokes at least 10-25 cigarettes a day~* Good general health~Exclusion Criteria:~* Subjects with a pacemaker or other ferromagnetic material in body.~* Prior exposure to NicVAX or any other nicotine vaccine.~* Use of systemic steroids or other immunosuppressive agent~* History of significant neurological, cardiovascular, hepatic, endocrine, renal, liver, psychiatric or thyroid illness~* Cancer or cancer treatment in last 5 years~* HIV infection~* Use of varenicline (Chantix), bupropion (Wellbutrin, Zyban), mecamylamine (Inversin), within 30 days prior to administration of NicVAX and for the duration of the study.~* Inability to fulfill all visits and examination procedures for approximately 20 weeks.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Healthy Smoker (Type: EXPERIMENTAL): There is only one arm to the study. All subjects will receive NicVax, \[123I\]5-I-A-85380,and Nicotine bitartrate.

Based on this trial design, predict the completion outcome and termination type (if applicable).